Compounds > 17-phenylprostaglandin-f2alpha

17-phenylprostaglandin-f2alpha and Rhinitis--Vasomotor

17-phenylprostaglandin-f2alpha has been researched along with Rhinitis--Vasomotor* in 1 studies

Other Studies

1 other study(ies) available for 17-phenylprostaglandin-f2alpha and Rhinitis--Vasomotor

Article	Year
Effect of 17 phenyl PGF2 alpha on nasal patency in man. Prostaglandins and medicine, 1979, Volume: 3, Issue:1 The effect of three different doses (12.5 microgram, 25 microgram and 50 microgram) of 17 phenyl PGF2 alpha on nasal patency in fourteen patients with vasomotor rhinitis was studied on separate occasions. In all subjects the three doses of the prostaglandin analogue increased nasal patency for varying duration. With the 50 microgram single dose the duration of action ranged between three hours and more than seven hours. There were no side effects in most of the patients. Topics: Dinoprost; Humans; Lacrimal Apparatus; Nasal Decongestants; Nose; Prostaglandins F, Synthetic; Rhinitis, Vasomotor	1979

Article

Year

Effect of 17 phenyl PGF2 alpha on nasal patency in man.

Prostaglandins and medicine, 1979, Volume: 3, Issue:1

The effect of three different doses (12.5 microgram, 25 microgram and 50 microgram) of 17 phenyl PGF2 alpha on nasal patency in fourteen patients with vasomotor rhinitis was studied on separate occasions. In all subjects the three doses of the prostaglandin analogue increased nasal patency for varying duration. With the 50 microgram single dose the duration of action ranged between three hours and more than seven hours. There were no side effects in most of the patients.

Topics: Dinoprost; Humans; Lacrimal Apparatus; Nasal Decongestants; Nose; Prostaglandins F, Synthetic; Rhinitis, Vasomotor

1979